{"id":"https://openalex.org/W1985158279","doi":"https://doi.org/10.2337/dc12-0808","title":"Comparative Pharmacokinetics and Insulin Action for Three Rapid-Acting Insulin Analogs Injected Subcutaneously With and Without Hyaluronidase","display_name":"Comparative Pharmacokinetics and Insulin Action for Three Rapid-Acting Insulin Analogs Injected Subcutaneously With and Without Hyaluronidase","publication_year":2012,"publication_date":"2012-10-07","ids":{"openalex":"https://openalex.org/W1985158279","doi":"https://doi.org/10.2337/dc12-0808","mag":"1985158279","pmid":"https://pubmed.ncbi.nlm.nih.gov/23043164","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3554283"},"language":"en","primary_location":{"id":"doi:10.2337/dc12-0808","doi":"https://doi.org/10.2337/dc12-0808","is_oa":true,"landing_page_url":"https://doi.org/10.2337/dc12-0808","pdf_url":null,"source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.2337/dc12-0808","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084625858","display_name":"Linda Morrow","orcid":"https://orcid.org/0000-0003-3252-4477","observed_orcids":["https://orcid.org/0000-0003-3252-4477"]},"institutions":[{"id":"https://openalex.org/I4210134048","display_name":"Profil Institute for Clinical Research","ror":"https://ror.org/03f2dkv17","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210134048"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Linda Morrow","raw_affiliation_strings":["Profil Institute for Clinical Research, Chula Vista, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Profil Institute for Clinical Research, Chula Vista, California","institution_ids":["https://openalex.org/I4210134048"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013159981","display_name":"Douglas B. Muchmore","orcid":"https://orcid.org/0000-0002-9300-3862","observed_orcids":["https://orcid.org/0000-0002-9300-3862"]},"institutions":[{"id":"https://openalex.org/I4210088034","display_name":"Halozyme Therapeutics (United States)","ror":"https://ror.org/001x5ea44","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088034"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Douglas B. Muchmore","raw_affiliation_strings":["and Halozyme Therapeutics, San Diego, California","and 2Halozyme Therapeutics, San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"and Halozyme Therapeutics, San Diego, California","institution_ids":["https://openalex.org/I4210088034"]},{"raw_affiliation_string":"and 2Halozyme Therapeutics, San Diego, California","institution_ids":["https://openalex.org/I4210088034"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044166679","display_name":"Marcus Hompesch","orcid":"https://orcid.org/0000-0001-5867-2131","observed_orcids":["https://orcid.org/0000-0001-5867-2131"]},"institutions":[{"id":"https://openalex.org/I4210134048","display_name":"Profil Institute for Clinical Research","ror":"https://ror.org/03f2dkv17","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210134048"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marcus Hompesch","raw_affiliation_strings":["Profil Institute for Clinical Research, Chula Vista, California","1Profil Institute for Clinical Research, Chula Vista, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Profil Institute for Clinical Research, Chula Vista, California","institution_ids":["https://openalex.org/I4210134048"]},{"raw_affiliation_string":"1Profil Institute for Clinical Research, Chula Vista, California","institution_ids":["https://openalex.org/I4210134048"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011791624","display_name":"Elizabeth A. Ludington","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088034","display_name":"Halozyme Therapeutics (United States)","ror":"https://ror.org/001x5ea44","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088034"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth A. Ludington","raw_affiliation_strings":["and Halozyme Therapeutics, San Diego, California","and 2Halozyme Therapeutics, San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"and Halozyme Therapeutics, San Diego, California","institution_ids":["https://openalex.org/I4210088034"]},{"raw_affiliation_string":"and 2Halozyme Therapeutics, San Diego, California","institution_ids":["https://openalex.org/I4210088034"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109281700","display_name":"Daniel E. Vaughn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088034","display_name":"Halozyme Therapeutics (United States)","ror":"https://ror.org/001x5ea44","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088034"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Daniel E. Vaughn","raw_affiliation_strings":["and Halozyme Therapeutics, San Diego, California","and 2Halozyme Therapeutics, San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"and Halozyme Therapeutics, San Diego, California","institution_ids":["https://openalex.org/I4210088034"]},{"raw_affiliation_string":"and 2Halozyme Therapeutics, San Diego, California","institution_ids":["https://openalex.org/I4210088034"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5109281700"],"corresponding_institution_ids":["https://openalex.org/I4210088034"],"apc_list":null,"apc_paid":null,"fwci":4.5309,"has_fulltext":true,"cited_by_count":60,"citation_normalized_percentile":{"value":0.94953969,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"36","issue":"2","first_page":"273","last_page":"275"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.9726999998092651,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.9726999998092651,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.012000000104308128,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14126","display_name":"Intramuscular injections and effects","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2711","display_name":"Emergency Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rapid-acting-insulin-analogues","display_name":"rapid-acting insulin analogs","score":0.9940000176429749},{"id":"https://openalex.org/keywords/insulin-aspart","display_name":"insulin aspart","score":0.9039999842643738},{"id":"https://openalex.org/keywords/insulin-glulisine","display_name":"insulin glulisine","score":0.9919999837875366},{"id":"https://openalex.org/keywords/insulin-lispro","display_name":"insulin lispro","score":1.0},{"id":"https://openalex.org/keywords/recombinant-human-hyaluronidase","display_name":"recombinant human hyaluronidase","score":0.9679999947547913},{"id":"https://openalex.org/keywords/rhuph20","display_name":"rHuPH20","score":0.8420000076293945},{"id":"https://openalex.org/keywords/subcutaneous-insulin-injection","display_name":"subcutaneous insulin injection","score":0.8149999976158142},{"id":"https://openalex.org/keywords/insulin-pharmacokinetics","display_name":"insulin pharmacokinetics","score":0.890999972820282},{"id":"https://openalex.org/keywords/insulin-absorption","display_name":"insulin absorption","score":0.6579999923706055}],"concepts":[{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.8160901069641113},{"id":"https://openalex.org/C2776486108","wikidata":"https://www.wikidata.org/wiki/Q3492616","display_name":"Insulin lispro","level":4,"score":0.8091456890106201},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7873270511627197},{"id":"https://openalex.org/C2779908123","wikidata":"https://www.wikidata.org/wiki/Q2754775","display_name":"Insulin aspart","level":4,"score":0.7623385190963745},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7382128238677979},{"id":"https://openalex.org/C46821324","wikidata":"https://www.wikidata.org/wiki/Q7094540","display_name":"Onset of action","level":2,"score":0.7176426649093628},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5791733264923096},{"id":"https://openalex.org/C87813604","wikidata":"https://www.wikidata.org/wiki/Q1242899","display_name":"Crossover study","level":4,"score":0.5726677179336548},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5524618625640869},{"id":"https://openalex.org/C2779946736","wikidata":"https://www.wikidata.org/wiki/Q2893248","display_name":"Regular insulin","level":4,"score":0.4773293137550354},{"id":"https://openalex.org/C2780375986","wikidata":"https://www.wikidata.org/wiki/Q904015","display_name":"Hyaluronidase","level":3,"score":0.46854957938194275},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4424520432949066},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.383526086807251},{"id":"https://openalex.org/C3019948211","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Human insulin","level":3,"score":0.31324005126953125},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.25570905208587646},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.09923791885375977},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.08332523703575134},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006821","descriptor_name":"Hyaluronoglucosaminidase","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006821","descriptor_name":"Hyaluronoglucosaminidase","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D007279","descriptor_name":"Injections, Subcutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061266","descriptor_name":"Insulin, Short-Acting","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D061266","descriptor_name":"Insulin, Short-Acting","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true}],"locations_count":6,"locations":[{"id":"doi:10.2337/dc12-0808","doi":"https://doi.org/10.2337/dc12-0808","is_oa":true,"landing_page_url":"https://doi.org/10.2337/dc12-0808","pdf_url":null,"source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3554283","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3554283/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3554283/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"Text"},{"id":"pmh:oai:europepmc.org:2892079","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3554283","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:23043164","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23043164","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes care","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.773.3087","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.773.3087","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/3e/52/273.PMC3554283.pdf","raw_type":"text"},{"id":"mag:2185749388","doi":null,"is_oa":false,"landing_page_url":"https://care.diabetesjournals.org/content/36/2/273.full.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"doi:10.2337/dc12-0808","doi":"https://doi.org/10.2337/dc12-0808","is_oa":true,"landing_page_url":"https://doi.org/10.2337/dc12-0808","pdf_url":null,"source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.8560000061988831,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1985158279.pdf","grobid_xml":"https://content.openalex.org/works/W1985158279.grobid-xml"},"referenced_works_count":14,"referenced_works":["https://openalex.org/W1967649339","https://openalex.org/W1968202154","https://openalex.org/W1977476566","https://openalex.org/W1988541637","https://openalex.org/W1998352922","https://openalex.org/W2019865251","https://openalex.org/W2025328110","https://openalex.org/W2057971952","https://openalex.org/W2070818248","https://openalex.org/W2111777136","https://openalex.org/W2122188282","https://openalex.org/W2158548553","https://openalex.org/W4237702143","https://openalex.org/W4242554702"],"related_works":["https://openalex.org/W2029160074","https://openalex.org/W1968202154","https://openalex.org/W2050322512","https://openalex.org/W2185749388","https://openalex.org/W2312323002","https://openalex.org/W2111777136","https://openalex.org/W2122188282","https://openalex.org/W2025328110","https://openalex.org/W7100283469","https://openalex.org/W2557705153"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"compare":[2],"the":[3,82,110,113,118],"pharmacokinetics":[4],"and":[5,14,62,72,95,116,131,160],"glucodynamics":[6],"of":[7,138,143,163],"three":[8],"rapid-acting":[9,146],"insulin":[10,60,139,149,164],"analogs":[11,83,147],"(aspart,":[12],"glulisine,":[13],"lispro)":[15],"injected":[16,46],"subcutaneously":[17,47],"with":[18,50,105,145,156],"or":[19,51],"without":[20,52],"recombinant":[21],"human":[22],"hyaluronidase":[23],"(rHuPH20).":[24],"RESEARCH":[25],"DESIGN":[26],"AND":[27],"METHODS:":[28],"This":[29],"double-blind":[30],"six-way":[31],"crossover":[32],"euglycemic":[33],"glucose":[34,75,97],"clamp":[35],"study":[36],"was":[37,45],"conducted":[38],"in":[39,112,125],"14":[40],"healthy":[41],"volunteers.":[42],"Each":[43],"analog":[44],"(0.15":[48],"units/kg)":[49],"rHuPH20.":[53],"RESULTS:":[54],"The":[55,102],"commercial":[56],"formulations":[57],"had":[58,84],"comparable":[59,88],"time-exposure":[61],"time-action":[63,154],"profiles":[64],"as":[65],"follows:":[66],"50%":[67,73,90,96],"exposure":[68,91,111,119],"at":[69,77,92,99],"123-131":[70],"min":[71,94],"total":[74],"infused":[76,98],"183-186":[78],"min.":[79,101],"With":[80],"rHuPH20,":[81],"faster":[85,129,158],"yet":[86],"still":[87],"profiles:":[89],"71-79":[93],"127-140":[100],"accelerated":[103,148],"absorption":[104],"rHuPH20":[106,144],"led":[107],"to":[108,127,133],"twice":[109],"first":[114],"hour":[115],"half":[117],"beyond":[120],"2":[121],"h,":[122],"which":[123],"resulted":[124],"13-":[126],"25-min":[128],"onset":[130,159],"40-":[132],"49-min":[134],"shorter":[135,161],"mean":[136],"duration":[137,162],"action.":[140,165],"CONCLUSIONS:":[141],"Coinjection":[142],"exposure,":[150],"producing":[151],"an":[152],"ultra-rapid":[153],"profile":[155],"a":[157]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":14},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":3}],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2016-06-24T00:00:00"}